SGX393 inhibits the CML mutant Bcr-AblT315I and preempts in vitro resistance when combined with nilotinib or dasatinib.
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Jeffrey W. Tyner Stephen K Burley |
| Publication date | March 26, 2008 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |